Por favor, use este identificador para citar o enlazar a este item: http://hdl.handle.net/10261/124717
COMPARTIR / EXPORTAR:
logo share SHARE logo core CORE BASE
Visualizar otros formatos: MARC | Dublin Core | RDF | ORE | MODS | METS | DIDL | DATACITE

Invitar a revisión por pares abierta
Campo DC Valor Lengua/Idioma
dc.contributor.authorRopy, Alaa-
dc.contributor.authorCabot, Gabriel-
dc.contributor.authorSánchez-Diener, Irina-
dc.contributor.authorAguilera, Cristina-
dc.contributor.authorMoyà, Bartolomé-
dc.contributor.authorAyala, Juan Alfonso-
dc.contributor.authorOliver, Antonio-
dc.date.accessioned2015-11-10T08:59:47Z-
dc.date.available2015-11-10T08:59:47Z-
dc.date.issued2015-
dc.identifierdoi: 10.1128/AAC.05150-14-
dc.identifierissn: 1098-6596-
dc.identifier.citationAntimicrobial Agents and Chemotherapy 59(7): 3925-3934 (2015)-
dc.identifier.urihttp://hdl.handle.net/10261/124717-
dc.description.abstractThis study aimed to characterize the role of Pseudomonas aeruginosa low-molecular-mass penicillin-binding proteins (LMM PBPs), namely, PBP4 (DacB), PBP5 (DacC), and PBP7 (PbpG), in peptidoglycan composition, β-lactam resistance, and ampC regulation. For this purpose, we constructed all single and multiple mutants of dacB, dacC, pbpG, and ampC from the wild-type P. aeruginosa PAO1 strain. Peptidoglycan composition was determined by high-performance liquid chromatography (HPLC), ampC expression by reverse transcription-PCR (RT-PCR), PBP patterns by a Bocillin FL-binding test, and antimicrobial susceptibility by MIC testing for a panel of β-lactams. Microscopy and growth rate analyses revealed no apparent major morphological changes for any of the mutants compared to the wild-type PAO1 strain. Of the single mutants, only dacC mutation led to significantly increased pentapeptide levels, showing that PBP5 is the major DD-carboxypeptidase in P. aeruginosa. Moreover, our results indicate that PBP4 and PBP7 play a significant role as DD-carboxypeptidase only if PBP5 is absent, and their DD-endopeptidase activity is also inferred. As expected, the inactivation of PBP4 led to a significant increase in ampC expression (around 50-fold), but, remarkably, the sequential inactivation of the three LMM PBPs produced a much greater increase (1,000-fold), which correlated with peptidoglycan pentapeptide levels. Finally, the β-lactam susceptibility profiles of the LMM PBP mutants correlated well with the ampC expression data. However, the inactivation of ampC in these mutants also evidenced a role of LMM PBPs, especially PBP5, in intrinsic β-lactam resistance. In summary, in addition to assessing the effect of P. aeruginosa LMM PBPs on peptidoglycan structure for the first time, we obtained results that represent a step forward in understanding the impact of these PBPs on β-lactam resistance, apparently driven by the interplay between their roles in AmpC induction, β-lactam trapping, and DD-carboxypeptidase/β-lactamase activity.-
dc.description.sponsorshipThis work was supported by the Ministerio de Economía y Competitividad of Spain and the Instituto de Salud Carlos III through the Spanish Network for the Research in Infectious Diseases (grants RD06/0008 and RD12/0015) and grants PS09/00033 and PI12/00103. The work at CBMSO was supported by grants BFU2009-09200 from the Ministerio de Economía y Competitividad of Spain and 223431 DIVINOCELL from the European Union. We acknowledge the predoctoral grant JAE/Predoc from the Consejo Superior de Investigaciones Cientificas to A.R. The study is also supported by the Direcció General d’Universitats, Recerca i Transferència del Coneixement del Govern de les Illes Balears, Spain.-
dc.publisherAmerican Society for Microbiology-
dc.relation.isversionofPublisher's version-
dc.rightsopenAccess-
dc.titleRole of Pseudomonas aeruginosa low-molecular-mass penicillin-binding proteins in AmpC expression, β-lactam resistance, and peptidoglycan structure-
dc.typeartículo-
dc.identifier.doi10.1128/AAC.05150-14-
dc.date.updated2015-11-10T08:59:48Z-
dc.description.versionPeer Reviewed-
dc.language.rfc3066eng-
dc.contributor.funderInstituto de Salud Carlos III-
dc.contributor.funderConsejo Superior de Investigaciones Científicas (España)-
dc.contributor.funderGovern de les Illes Balears-
dc.contributor.funderMinisterio de Economía y Competitividad (España)-
dc.relation.csic-
dc.identifier.funderhttp://dx.doi.org/10.13039/501100004587es_ES
dc.identifier.funderhttp://dx.doi.org/10.13039/501100003339es_ES
dc.identifier.funderhttp://dx.doi.org/10.13039/501100003329es_ES
dc.identifier.pmid25896695-
dc.type.coarhttp://purl.org/coar/resource_type/c_6501es_ES
item.openairetypeartículo-
item.grantfulltextopen-
item.cerifentitytypePublications-
item.openairecristypehttp://purl.org/coar/resource_type/c_18cf-
item.fulltextWith Fulltext-
Aparece en las colecciones: (CBM) Artículos
Ficheros en este ítem:
Fichero Descripción Tamaño Formato
Ayala Juan A Role of Pseudomonas.pdf514,73 kBAdobe PDFVista previa
Visualizar/Abrir
Show simple item record

CORE Recommender

PubMed Central
Citations

37
checked on 07-abr-2024

SCOPUSTM   
Citations

60
checked on 15-abr-2024

WEB OF SCIENCETM
Citations

58
checked on 26-feb-2024

Page view(s)

297
checked on 23-abr-2024

Download(s)

330
checked on 23-abr-2024

Google ScholarTM

Check

Altmetric

Altmetric


Artículos relacionados:


NOTA: Los ítems de Digital.CSIC están protegidos por copyright, con todos los derechos reservados, a menos que se indique lo contrario.